JAMIE PRICE: Open Payments
NPI 1497930515 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 51 payments from 19 companies in 2025. Trend: 2023 $1,187 · 2024 $1,076 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $270 |
| Amgen Inc. | 12 | $199 |
| Incyte Corporation | 3 | $176 |
| LEO Pharma Inc. | 4 | $169 |
| Regeneron Healthcare Solutions, Inc. | 3 | $156 |
| ABBVIE INC. | 6 | $103 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $36 |
Products named: DUPIXENT, Otezla, Opzelura, ANZUPGO, SKYRIZI, Cabtreo, Winlevi, TREMFYA.
Industry payments across NJ — which companies pay providers there.
